Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dihydroartemisinin tablets versus hydroxychloroquine for discoid lupus erythematosus
CTR20253338Phase 2Active
- Sponsor
- Institute of Chinese Materia Medica
- Start
- Aug 2025
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dihydroartemisinin in discoid lupus erythematosus (DLE), sponsored by Institute of Chinese Materia Medica. Started Aug 2025; status: active.
02
Drugs
dihydroartemisinin
03
Conditions
discoid lupus erythematosus (DLE)
Beyond the preview
Go deeper on CTR20253338.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20253338.